Dr. Sandra Croak-Brossman, BioSante Pharmaceuticals

<a class="taxInlineTagLink" id="ORCRP001916" title="BioSante Pharmaceuticals Incorporated" href="/topic/economy-business-finance/biosante-pharmaceuticals-incorporated-ORCRP001916.topic">BioSante Pharmaceuticals</a>, Inc. announced the appointment of Sandra Croak-Brossman, MS, Ph.D., as Vice President, Regulatory Affairs and Quality Assurance.<br>
<br>
Dr. Croak-Brossman joins BioSante with over 24 years of experience in the pharmaceutical industry. She has held a variety of regulatory positions and has led operations at both a U.S. and global level. Dr. Croak-Brossmans work experience includes positions at Boehringer Ingelheim, <a class="taxInlineTagLink" id="ORCRP012075" title="Pfizer Inc." href="/topic/economy-business-finance/pfizer-inc.-ORCRP012075.topic">Pfizer</a> and <a class="taxInlineTagLink" id="ORCRP017190" title="Abbott Laboratories" href="/topic/economy-business-finance/chemical-industry/pharmaceuticals/abbott-laboratories-ORCRP017190.topic">Abbott Laboratories</a>.<br>
<br>
Importantly, while at Pfizer, Dr. Croak-Brossman was the worldwide regulatory lead for Viagra. Her experience as a regulatory lead in the <a class="taxInlineTagLink" id="HEPHC0000030" title="Sexual Dysfunction" href="/topic/health/physical-conditions/sexual-dysfunction-HEPHC0000030.topic">sexual dysfunction</a> therapeutic market makes her uniquely qualified to manage regulatory projects as BioSante progresses towards the NDA submission for LibiGel® (<a class="taxInlineTagLink" id="HHA000100" title="Testosterone" href="/topic/health/human-body/testosterone-HHA000100.topic">testosterone</a> gel). Dr. Croak-Brossman earned her MS and Ph.D. in Quantitative <a class="taxInlineTagLink" id="HEMSP00003" title="Genetics" href="/topic/health/medical-specialization/genetics-HEMSP00003.topic">Genetics</a> and Animal Breeding from Purdue University and conducted her Post-Doctoral Fellowship at <a class="taxInlineTagLink" id="OREDU000066" title="Cornell University" href="/topic/education/colleges-universities/cornell-university-OREDU000066.topic">Cornell University</a>.

( August 4, 2011 )

BioSante Pharmaceuticals, Inc. announced the appointment of Sandra Croak-Brossman, MS, Ph.D., as Vice President, Regulatory Affairs and Quality Assurance.

Dr. Croak-Brossman joins BioSante with over 24 years of experience in the pharmaceutical industry. She has held a variety of regulatory positions and has led operations at both a U.S. and global level. Dr. Croak-Brossmans work experience includes positions at Boehringer Ingelheim, Pfizer and Abbott Laboratories.

Importantly, while at Pfizer, Dr. Croak-Brossman was the worldwide regulatory lead for Viagra. Her experience as a regulatory lead in the sexual dysfunction therapeutic market makes her uniquely qualified to manage regulatory projects as BioSante progresses towards the NDA submission for LibiGel® (testosterone gel). Dr. Croak-Brossman earned her MS and Ph.D. in Quantitative Genetics and Animal Breeding from Purdue University and conducted her Post-Doctoral Fellowship at Cornell University.

Comments (0)

Add comments | Discussion FAQ

Currently there are no comments. Be the first to comment!

Comments are filtered for language and registration is required. The Times makes no guarantee of comments' factual accuracy. Readers may report inappropriate comments by clicking the Report Abuse link next to a comment. Here are the full legal terms you agree to by using this comment form.